Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition (Q34962673)

1

1 reference

5 August 2017

W J Van Gaal

2

1 reference

5 August 2017

G G L Biondi Zoccai

3

1 reference

5 August 2017

P Agostoni

4

1 reference

5 August 2017

R A Latini

5

1 reference

5 August 2017

I Porto

7

1 reference

5 August 2017

A P Banning

QJM: An International Journal of Medicine

8

1 reference

5 August 2017

language of work or name

English

0 references

publication date

13 March 2009

1 reference

5 August 2017

1 reference

5 August 2017

102

1 reference

5 August 2017

369-378

1 reference

5 August 2017

6

1 reference

5 August 2017

Baseline troponin level: key to understanding the importance of post-PCI troponin elevations

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCP005

Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCP005

Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCP005

A simple hint to improve Robinson and Dickersin's highly sensitive PubMed search strategy for controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCP005

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCP005

Prognostic value of cardiac troponin I elevation after percutaneous coronary intervention in patients with chronic renal insufficiency: a 12-month outcome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCP005

Biochemical detection of minor myocardial injury after elective, uncomplicated, successful percutaneous coronary intervention in patients with stable angina: clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCP005

Prognostic implication of cardiac troponin T increase following stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCP005

Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCP005

Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCP005

Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCP005

Predictors and prognostic value of myocardial injury following stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCP005

Prognostic importance of troponin T and creatine kinase after elective angioplasty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCP005

Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCP005

Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCP005

Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCP005

Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCP005

Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non-urgent percutaneous coronary intervention: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCP005

Effect of distal embolization on myocardial perfusion reserve after percutaneous coronary intervention: a quantitative magnetic resonance perfusion study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCP005

Prognostic value of troponin after elective percutaneous coronary intervention: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCP005

Troponin Elevation After Percutaneous Coronary Intervention Directly Represents the Extent of Irreversible Myocardial Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCP005